Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first‐line combination antiretroviral therapy

Publisher: John Wiley & Sons Inc

E-ISSN: 1468-1293|16|9|553-562

ISSN: 1464-2662

Source: HIV MEDICINE, Vol.16, Iss.9, 2015-10, pp. : 553-562

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content